Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

NCT03090386 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03090386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03090386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
February 25, 2017
Completion date
November 15, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor